TickerFactsScreenerDevelopers

X4 Pharmaceuticals, Inc (XFOR) — Operating Income

Annual figures by fiscal year, from SEC filings.

2016: -$24.35M2017: -$22.25M2018: -$29.09M2019: -$51.70M2020: -$59.87M2021: -$85.11M2022: -$87.57M2023: -$107.52M2024: -$36.40M2025: -$86.88M-$86.88M
2016Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$86.88M-138.7%
2024-$36.40M+66.1%
2023-$107.52M-22.8%
2022-$87.57M-2.9%
2021-$85.11M-42.1%
2020-$59.87M-15.8%
2019-$51.70M-77.8%
2018-$29.09M-30.7%
2017-$22.25M+8.6%
2016-$24.35M—